Quantcast

Latest Ribbon symbolism Stories

2014-06-04 11:26:06

American Heart Association Study Highlights: -About 12 percent of older breast cancer patients developed heart failure within three years, often as a result of the cancer drugs and treatments. -Only a third of older breast cancer patients saw a cardiologist within 90 days of developing heart problems. -Those who saw a cardiologist were more likely to receive standard drugs for heart failure than those who didn’t. Only a third of older breast cancer patients saw a cardiologist...

2014-06-04 04:21:41

SUZHOU, China, June 4, 2014 /PRNewswire/ -- MicroDiag Biomedicine, a leading molecular diagnostic technology inventor based in Suzhou, China, was invited to present a major breakthrough technology developed by the MicroDiag team, a serum circulating DNA mutation detection assay, at the annual meeting of the American Society of Clinical Oncology (ASCO). "We are very proud to be the first Chinese company invited to present research progress at the ASCO annual meeting," said Tao Wang,...

2014-06-03 23:08:44

ResearchMoz.us include new market research report "Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs" to its huge collection of research reports. Albany, NY (PRWEB) June 03, 2014 "Breast Cancer Therapeutics in Major Developed Markets to 2020 – Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs", which provides in-depth analysis of breast...

2014-06-03 16:24:50

BRONX, N.Y., June 3, 2014 /PRNewswire-USNewswire/ -- A test that counts the number of locations in tumor specimens where tumor cells may invade blood vessels predicted the risk of distant spread, or metastasis, for the most common type of breast cancer. http://photos.prnewswire.com/prnvar/20140603/93895 The study was led by researchers at the National Cancer Institute (NCI)?designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and...

2014-06-03 16:24:32

FAIRFAX, Va., June 3, 2014 /PRNewswire/ -- Nancy Cappello, Ph.D., Executive Director and Founder of Are You Dense, Inc., will join Fairfax Radiological Consultants to provide opening remarks at a special, invitation-only event this evening. Are You Dense (www.areyoudense.org) is an organization dedicated to informing the public about dense breast tissue and its significance for the early detection of breast cancer. The open house event will introduce local physicians and office...

2014-06-03 11:48:40

University of Colorado Denver At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells (CSCs). The drug was generally well tolerated, and several of the 26 patients with advanced solid tumors experienced stable disease for greater than six months. Three trials...

2014-06-03 08:32:24

Two Studies Presented at ASCO® Demonstrate Company's Ability to Develop Tests to Predict Disease Aggressiveness Across Various Cancers REDWOOD CITY, Calif., June 3, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of two studies demonstrating the ability of its Oncotype DX(®) test and a new 16-gene panel to predict disease aggressiveness and clinical outcomes in prostate and renal cancers, respectively. These results, presented at the American...

2014-06-03 08:32:20

First U.S. Installs of Next-generation Breast Imaging Technology at Fairfax Radiological Breast Diagnostic Imaging Center in D.C. and Phelps Memorial Hospital in NY MILWAUKEE, June 3, 2014 /PRNewswire/ -- GE Healthcare today announced FDA approval and the U.S. launch of their new breast imaging technology, the Invenia(TM) ABUS, proven to help clinicians find 35.7% more cancers in women with dense breasts than mammograms alone(1). In keeping with a strong commitment to furthering the...

2014-06-03 08:31:33

ROCKVILLE, Md., June 3, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that Franklin C. Salisbury, Jr. has joined the Company's Board of Directors. http://photos.prnewswire.com/prnvar/20010620/ENMDLOGO Since 1998, Mr. Salisbury has served as president of the National Foundation for Cancer Research (NFCR), an organization that supports healthcare...

2014-06-03 08:31:30

Pathway Analysis Confirms the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, June 3, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today the presentation of data identifying multiple novel biomarkers as potential targets for immunotherapeutic agents in triple negative breast cancer (TNBC), an aggressive form of breast cancer in which the cancer cells lack estrogen receptors...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related